Unravelling Erucin-Protein Binding Interactions through Multi-Spectroscopic and Molecular Docking Approaches: Mechanistic Perspectives on Antiglycation Activity

Abstract

Advanced glycation end products (AGEs) are key mediators in the pathogenesis of diabetic complications, necessitating the exploration of potent antiglycation agents. Herein, the antiglycation potential of 4-(methylthio)butyl isothiocyanate (4-MTBITC, Erucin,...